NEWS On the Health Affairs Blog: Seabury and Sood Examine Policies to Promote Development of Antimicrobial Drugs 5/18/17

In the latest post on the IVI-sponsored Health Affairs blog series, Seth Seabury and Neeraj Sood examine the challenges to addressing the significant threat that antimicrobial resistant infections pose to human health. In their commentary, Seabury and Sood focus on three of the most commonly proposed policies to promote the development of new antimicrobials: market entry awards, exclusivity extensions and priority review vouchers. The authors conclude that "a hybrid approach that combined a priority review voucher with a briefer exclusivity extension might be an effective compromise that lowered some of the cost, but these should be coupled with additional efforts to prevent overuse of any new antimicrobials developed."

Read more here.